Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Gross Profit of $1.10 billion for fiscal year 2025.
WEST PHARMACEUTICAL SERVICES INC Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $1.10B | +10.6% |
| 2024 | $998.50M | -11.6% |
| 2023 | $1.13B | -0.6% |
| 2022 | $1.14B | -3.4% |
| 2021 | $1.18B | +53.1% |
| 2020 | $767.80M | +26.8% |
| 2019 | $605.70M | +11.1% |
| 2018 | $545.40M | +6.3% |
| 2017 | $512.90M | +2.3% |
| 2016 | $501.40M | +10.0% |
| 2015 | $455.80M | +1.8% |
| 2014 | $447.80M | +3.0% |
| 2013 | $434.70M | +12.1% |
| 2012 | $387.70M | +14.3% |
| 2011 | $339.30M | +6.7% |
| 2010 | $318.10M | +4.8% |
| 2009 | $303.60M | +0.3% |
| 2008 | $302.60M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $294.30M | +11.2% | +7.4% |
| June 30, 2025 | $273.90M | +19.1% | +18.1% |
| March 31, 2025 | $231.90M | +0.7% | -12.4% |
| September 30, 2024 | $264.70M | -8.2% | +15.1% |
| June 30, 2024 | $230.00M | -21.1% | -0.1% |
| March 31, 2024 | $230.20M | -15.1% | -20.2% |
| September 30, 2023 | $288.30M | +7.6% | -1.1% |
| June 30, 2023 | $291.40M | -9.4% | +7.4% |
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +10.6% in Gross Profit compared to the prior fiscal year.
- Over the 2008–2025 period, WEST PHARMACEUTICAL SERVICES INC’s gross profit has grown by 264.8% (from $302.60 million to $1.10 billion).
- The most recent figure is from WEST PHARMACEUTICAL SERVICES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: